SynthesisClinical epigenetics2023

Efficacy and safety of FDA-approved IDH inhibitors in the treatment of IDH mutated acute myeloid leukemia: a systematic review and meta-analysis.

Xiu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.